Literature DB >> 27053858

Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.

Zhen-Ya Lu1, Zhou Shao1, Ya-Li Li1, Muhuyati Wulasihan1, Xin-Hua Chen1.   

Abstract

AIM: To investigate the prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) in a Chinese population.
METHODS: A total of 1948 adults from China was followed for 8 years. A cross-sectional study was performed to investigate the prevalence of NAFLD at baseline, and then the participants were followed for 8 years to investigate risk factors for the development of NAFLD.
RESULTS: A total of 1948 participants were enrolled at baseline, of whom 691 were diagnosed with NAFLD. During the 8-year follow-up, 337 baseline NAFLD-free participants developed NAFLD. They had a greater increase in body mass index (BMI), serum uric acid, fasting plasma glucose, very low-density lipoprotein cholesterol and a considerable decrease in high-density lipoprotein cholesterol. 123 participants who had NAFLD at baseline lost NAFLD during the 8-year follow-up period. They had a greater decrease in BMI, fasting plasma glucose, triglycerides, total cholesterol, low-density lipoprotein cholesterol, alanine aminotransferase, aspartate aminotransferase, and γ-glutamyl transpeptidase.
CONCLUSION: NAFLD is prevalent in Chinese population with a rapidly increasing tendency. It can be reversed when patients lose their weight, control their hyperlipidemia and hyperglycemia, and reduce the liver enzyme levels.

Entities:  

Keywords:  Follow-up; Non-alcoholic fatty liver disease; Prevalence; Risk factors

Mesh:

Substances:

Year:  2016        PMID: 27053858      PMCID: PMC4814652          DOI: 10.3748/wjg.v22.i13.3663

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  AGA technical review on nonalcoholic fatty liver disease.

Authors:  Arun J Sanyal
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

2.  Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases.

Authors:  Min De Zeng; Jian Gao Fan; Lun Gen Lu; You Ming Li; Cheng Wei Chen; Bing Yuan Wang; Yi Min Mao
Journal:  J Dig Dis       Date:  2008-05       Impact factor: 2.325

3.  Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012.

Authors:  Kenichi Nishioji; Yoshio Sumida; Mai Kamaguchi; Naomi Mochizuki; Masao Kobayashi; Takeshi Nishimura; Kanji Yamaguchi; Yoshito Itoh
Journal:  J Gastroenterol       Date:  2014-03-12       Impact factor: 7.527

4.  Fatty liver and the metabolic syndrome among Shanghai adults.

Authors:  Jian-Gao Fan; June Zhu; Xing-Jian Li; Lan Chen; Yuan-San Lu; Lui Li; Fei Dai; Feng Li; Shi-Yao Chen
Journal:  J Gastroenterol Hepatol       Date:  2005-12       Impact factor: 4.029

5.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

6.  The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.

Authors:  George N Ioannou; Edward J Boyko; Sum P Lee
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

Review 7.  Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Authors:  Geoffrey C Farrell; Claire Z Larter
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

8.  Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women.

Authors:  W F DeNino; A Tchernof; I J Dionne; M J Toth; P A Ades; C K Sites; E T Poehlman
Journal:  Diabetes Care       Date:  2001-05       Impact factor: 19.112

9.  Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans.

Authors:  Hong-Kyu Kim; Joong-Yeol Park; Ki-Up Lee; Go-Eun Lee; Seong-Hoon Jeon; Jin-Ho Kim; Chul-Hee Kim
Journal:  Am J Med Sci       Date:  2009-02       Impact factor: 2.378

10.  Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

View more
  14 in total

Review 1.  Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.

Authors:  Judith Aron-Wisnewsky; Chloé Vigliotti; Julia Witjes; Phuong Le; Adriaan G Holleboom; Joanne Verheij; Max Nieuwdorp; Karine Clément
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-09       Impact factor: 46.802

2.  Plant-derived oleanolic acid ameliorates markers associated with non-alcoholic fatty liver disease in a diet-induced pre-diabetes rat model.

Authors:  Mlindeli Gamede; Lindokuhle Mabuza; Phikelelani Ngubane; Andile Khathi
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-01       Impact factor: 3.168

3.  Lipid Regulation Effects of Raw and Processed Notoginseng Radix Et Rhizome on Steatotic Hepatocyte L02 Cell.

Authors:  Zhu Chen; Chunmei Li; Caixia Yang; Ronghua Zhao; Xiaojian Mao; Jie Yu
Journal:  Biomed Res Int       Date:  2016-08-24       Impact factor: 3.411

4.  Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary Report.

Authors:  Ivan M Petyaev; Pavel Y Dovgalevsky; Natalia E Chalyk; Victor A Klochkov; Nigel H Kyle; Yuriy K Bashmakov
Journal:  Int J Chronic Dis       Date:  2018-04-01

5.  Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study.

Authors:  Yang Zou; Meng Yu; Guotai Sheng
Journal:  Lipids Health Dis       Date:  2020-06-20       Impact factor: 3.876

6.  Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population.

Authors:  Yuan Li; Shousheng Liu; Yuqiang Gao; Huan Ma; Shuhui Zhan; Yan Yang; Yongning Xin; Shiying Xuan
Journal:  BMC Biochem       Date:  2019-02-06       Impact factor: 4.059

7.  Fatty liver is a risk factor for liver metastasis in Chinese patients with non-small cell lung cancer.

Authors:  Wenyu Wu; Haiyan Liao; Weilin Ye; Xi Li; Jian Zhang; Junguo Bu
Journal:  PeerJ       Date:  2019-03-14       Impact factor: 2.984

8.  Relationship between Methyl Tertiary Butyl Ether Exposure and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Petrol Station Attendants in Southern China.

Authors:  Jianping Yang; Qinzhi Wei; Xiaochun Peng; Xiaowu Peng; Jianhui Yuan; Dalin Hu
Journal:  Int J Environ Res Public Health       Date:  2016-09-23       Impact factor: 3.390

9.  Association between Nonalcoholic Fatty Liver Disease and Carotid Artery Disease in a Community-Based Chinese Population: A Cross-Sectional Study.

Authors:  Yu-Chen Guo; Yong Zhou; Xing Gao; Yan Yao; Bin Geng; Qing-Hua Cui; Ji-Chun Yang; Hong-Pu Hu
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628

10.  Association between serum uric acid and nonalcoholic fatty liver disease in community patients with type 2 diabetes mellitus.

Authors:  Linxin Xu; Ting Li; Jianhong Yin; Gang Lin; Yali Xu; Yi Ren; Yan Wang; Jing Yang; Liming Chen
Journal:  PeerJ       Date:  2019-08-26       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.